These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 15166437)
1. Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3. Yu H; Babiuk LA; van Drunen Littel-van den Hurk S J Gen Virol; 2004 Jun; 85(Pt 6):1533-1543. PubMed ID: 15166437 [TBL] [Abstract][Full Text] [Related]
2. Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes. Jiao X; Wang RY; Qiu Q; Alter HJ; Shih JW J Gen Virol; 2004 Jun; 85(Pt 6):1545-1553. PubMed ID: 15166438 [TBL] [Abstract][Full Text] [Related]
3. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA. Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465 [TBL] [Abstract][Full Text] [Related]
4. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein. Lazdina U; Hultgren C; Frelin L; Chen M; Lodin K; Weiland O; Leroux-Roels G; Quiroga JA; Peterson DL; Milich DR; Sällberg M J Gen Virol; 2001 Jun; 82(Pt 6):1299-1308. PubMed ID: 11369873 [TBL] [Abstract][Full Text] [Related]
5. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs. Sugauchi F; Wang RY; Qiu Q; Jin B; Alter HJ; Shih JW J Infect Dis; 2006 Feb; 193(4):563-72. PubMed ID: 16425136 [TBL] [Abstract][Full Text] [Related]
6. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3. Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764 [TBL] [Abstract][Full Text] [Related]
7. Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants. Qiu Q; Wang RY; Jiao X; Jin B; Sugauchi F; Grandinetti T; Alter HJ; Shih JW Vaccine; 2008 Oct; 26(43):5527-5534. PubMed ID: 18675871 [TBL] [Abstract][Full Text] [Related]
8. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice. Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles. Brinster C; Chen M; Boucreux D; Paranhos-Baccala G; Liljeström P; Lemmonier F; Inchauspé G J Gen Virol; 2002 Feb; 83(Pt 2):369-381. PubMed ID: 11807230 [TBL] [Abstract][Full Text] [Related]
10. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice. Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843 [TBL] [Abstract][Full Text] [Related]
11. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization. Encke J; zu Putlitz J; Stremmel W; Wands JR Arch Virol; 2003 Mar; 148(3):435-48. PubMed ID: 12607097 [TBL] [Abstract][Full Text] [Related]
12. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice. Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486 [TBL] [Abstract][Full Text] [Related]
13. DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response. Jiao X; Wang RY; Feng Z; Hu G; Alter HJ; W -K Shih J J Viral Hepat; 2004 Jan; 11(1):18-26. PubMed ID: 14738554 [TBL] [Abstract][Full Text] [Related]
14. Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model. Wedemeyer H; Gagneten S; Davis A; Bartenschlager R; Feinstone S; Rehermann B Gastroenterology; 2001 Nov; 121(5):1158-66. PubMed ID: 11677208 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous use of natural adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific immune responses. Alizadeh S; Irani S; Bolhassani A; Sadat SM Immunol Lett; 2019 Aug; 212():70-80. PubMed ID: 31254535 [TBL] [Abstract][Full Text] [Related]
16. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice. Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154 [TBL] [Abstract][Full Text] [Related]
17. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice. Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300 [TBL] [Abstract][Full Text] [Related]
18. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus. Arribillaga L; de Cerio AL; Sarobe P; Casares N; Gorraiz M; Vales A; Bruna-Romero O; Borrás-Cuesta F; Paranhos-Baccala G; Prieto J; Ruiz J; Lasarte JJ Vaccine; 2002 Dec; 21(3-4):202-10. PubMed ID: 12450695 [TBL] [Abstract][Full Text] [Related]
19. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. McCluskie MJ; Weeratna RD; Payette PJ; Davis HL FEMS Immunol Med Microbiol; 2002 Feb; 32(3):179-85. PubMed ID: 11934561 [TBL] [Abstract][Full Text] [Related]
20. Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice. Behzadi MA; Alborzi A; Kalani M; Pouladfar G; Dianatpour M; Ziyaeyan M Viral Immunol; 2016 Apr; 29(3):138-47. PubMed ID: 26909520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]